From US$ 1.33 Billion to US$ 2.75 Billion: The Growth Story of the Acromegaly and Gigantism Treatment Industry
Acromegaly and gigantism are rare endocrine disorders primarily associated with excessive production of growth hormone, often resulting from abnormalities involving the pituitary gland. These conditions can cause progressive changes in physical appearance, metabolic complications, cardiovascular risks, musculoskeletal abnormalities, and other health concerns. Growing awareness of hormonal...
0 Комментарии
0 Поделились